Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study.
Andrea VisentinFrancesca Romana MauroFrancesca CibienCandida VitaleGianluigi RedaAlberto FresaStefania CiolliDaniela PietrasantaMonia MarchettiRoberta MurruMassimo GentileGian Matteo RigolinFrancesca Maria QuagliaLydia ScarfòPaolo SportolettiStefano PravatoFrancesco PiazzaMarta CosciaLuca LaurentiStefano MolicaRobin FoàAntonio CuneoLivio TrentinPublished in: American journal of hematology (2021)